Display options
Cite
Xiong X, Liu L, Xu F, et al. Feprazone Ameliorates TNF-α-Induced Loss of Aggrecan via Inhibition of the SOX-4/ADAMTS-5 Signaling Pathway. ACS Omega. 2021;6(11):7638-7645doi: 10.1021/acsomega.0c06212.
Xiong, X., Liu, L., Xu, F., Wu, X., Yin, Z., Dong, Y., & Qian, P. (2021). Feprazone Ameliorates TNF-α-Induced Loss of Aggrecan via Inhibition of the SOX-4/ADAMTS-5 Signaling Pathway. ACS omega, 6(11), 7638-7645. https://doi.org/10.1021/acsomega.0c06212
Xiong, Xiaoyang, et al. "Feprazone Ameliorates TNF-α-Induced Loss of Aggrecan via Inhibition of the SOX-4/ADAMTS-5 Signaling Pathway." ACS omega vol. 6,11 (2021): 7638-7645. doi: https://doi.org/10.1021/acsomega.0c06212
Xiong X, Liu L, Xu F, Wu X, Yin Z, Dong Y, Qian P. Feprazone Ameliorates TNF-α-Induced Loss of Aggrecan via Inhibition of the SOX-4/ADAMTS-5 Signaling Pathway. ACS Omega. 2021 Mar 12;6(11):7638-7645. doi: 10.1021/acsomega.0c06212. eCollection 2021 Mar 23. PMID: 33778274; PMCID: PMC7992146.
Copy Download .nbib Format: NLM
Share it on

ACS Omega. 2021 Mar 12;6(11):7638-7645. doi: 10.1021/acsomega.0c06212. eCollection 2021 Mar 23.

Feprazone Ameliorates TNF-α-Induced Loss of Aggrecan via Inhibition of the SOX-4/ADAMTS-5 Signaling Pathway.

ACS omega

Xiaoyang Xiong, Liang Liu, Feng Xu, Xiaofeng Wu, Zifei Yin, Yi Dong, Pingkang Qian

Affiliations

  1. Department of Joint and orthopedics, Traditional Chinese Medicine Hospital of Kunshan, Suzhou, Jiangsu 215300, China.

PMID: 33778274 PMCID: PMC7992146 DOI: 10.1021/acsomega.0c06212

[No abstract available.]

© 2021 The Authors. Published by American Chemical Society.

Conflict of interest statement

The authors declare no competing financial interest.

References

  1. Curr Opin Cell Biol. 2006 Dec;18(6):723-9 - PubMed
  2. Arthritis Res Ther. 2014 Sep 26;16(5):441 - PubMed
  3. Arthritis Rheum. 2003 Jan;48(1):119-33 - PubMed
  4. Birth Defects Res C Embryo Today. 2005 Sep;75(3):200-12 - PubMed
  5. Biochem Pharmacol. 2010 Jul 1;80(1):13-21 - PubMed
  6. J Biol Chem. 2006 Aug 25;281(34):24124-37 - PubMed
  7. Inflammopharmacology. 2018 Oct;26(5):1219-1232 - PubMed
  8. Nucleic Acids Res. 1999 Mar 15;27(6):1409-20 - PubMed
  9. Biochem Pharmacol. 2018 Feb;148:222-237 - PubMed
  10. J Orthop Res. 2015 Jan;33(1):47-55 - PubMed
  11. Osteoarthritis Cartilage. 2006 Feb;14(2):95-100 - PubMed
  12. J Biol Chem. 2007 Apr 13;282(15):11101-9 - PubMed
  13. Ann Rheum Dis. 1975 Apr;34(2):190-4 - PubMed
  14. Osteoarthritis Cartilage. 2001;9 Suppl A:S69-75 - PubMed
  15. Science. 1999 Jun 4;284(5420):1664-6 - PubMed
  16. Eur J Pharmacol. 2019 Aug 5;856:172387 - PubMed
  17. Pharmatherapeutica. 1983;3(6):393-7 - PubMed
  18. Arthritis Res Ther. 2005;7(5):R1091-102 - PubMed
  19. Arthritis Rheum. 2000 Sep;43(9):1916-26 - PubMed
  20. Biochem Biophys Res Commun. 2002 Jul 26;295(4):937-44 - PubMed
  21. Cell Mol Life Sci. 2002 Jan;59(1):45-53 - PubMed
  22. Lasers Med Sci. 2016 Aug;31(6):1051-9 - PubMed
  23. J Biol Chem. 1999 Aug 13;274(33):23443-50 - PubMed
  24. Biomacromolecules. 2016 Oct 10;17(10):3145-3152 - PubMed
  25. Redox Biol. 2018 Apr;14:72-81 - PubMed
  26. Genes Dev. 2002 Nov 1;16(21):2813-28 - PubMed
  27. J Bone Joint Surg Am. 1970 Apr;52(3):424-34 - PubMed
  28. Dev Dyn. 1997 Aug;209(4):377-86 - PubMed
  29. Development. 2011 Apr;138(8):1507-19 - PubMed
  30. FASEB J. 2019 Jan;33(1):619-630 - PubMed
  31. Rheum Dis Clin North Am. 2013 Feb;39(1):1-19 - PubMed
  32. J Immunol. 2002 Feb 1;168(3):1405-12 - PubMed
  33. Toxicol Appl Pharmacol. 1982 Jun 30;64(2):255-70 - PubMed
  34. Kidney Int. 2018 Aug;94(2):280-291 - PubMed
  35. Clin Ther. 1981;3(5):349-55 - PubMed
  36. Protein Cell. 2017 Aug;8(8):560-572 - PubMed
  37. Mol Cell. 2018 Feb 1;69(3):398-411.e6 - PubMed
  38. Arthritis Rheum. 2002 Oct;46(10):2648-57 - PubMed
  39. Biochem Soc Symp. 2003;(70):115-23 - PubMed

Publication Types